Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Bayesian interim analysis of phase II cancer clinical trials
Daniel F. Heitjan
Clinical Sciences
Clinical Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
71
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bayesian interim analysis of phase II cancer clinical trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Mathematics
Interim Analysis
100%
Bayesian Analysis
75%
Cancer
73%
Persuasion
71%
Clinical Trials
67%
Design
44%
Evidence
35%
Standards
23%
Alternatives
17%
Posterior Probability
16%
Therapy
16%
Error Probability
16%
Termination
14%
Optimise
14%
Exceed
13%
Critical value
13%
Null
12%
Optimality
11%
Calculate
10%
Strictly
10%
Imply
8%
Medicine & Life Sciences
Bayes Theorem
87%
Phase II Clinical Trials
86%
Persuasive Communication
62%
Neoplasms
23%
Investigational Therapies
17%
Therapeutics
2%